| Literature DB >> 17286612 |
Dawn J Mazzatti1, Andrew White, Rosalyn J Forsey, Jonathan R Powell, Graham Pawelec.
Abstract
The adaptive immune response requires waves of T-cell clonal expansion on contact with altered self and contraction after elimination of antigen. In the case of persisting antigen, as occurs for example in cytomegalovirus or Epstein-Barr virus infection, this critical process can become dysregulated and responding T-cells enter into a dysfunctional senescent state. Longitudinal studies suggest that the presence of increased numbers of such T-cells is a poor prognostic factor for survival in the very elderly. Understanding the nature of the defects in these T-cells might facilitate intervention to improve immunity in the elderly. The process of clonal expansion under chronic antigenic stress can be modelled in vitro using continuously cultured T-cells. Here, we have used cDNA array technology to investigate differences in gene expression in a set of five different T-cell clones at early, middle and late passage in culture. Differentially expressed genes were confirmed by real-time polymerase chain reaction, and relationships between these assessed using Ingenuity Systems evidence-based association analysis. Several genes and chemokines related to induction of apoptosis and signal transduction pathways regulated by transforming growth factor beta (TGFbeta), epidermal growth factor (EGF), fos and beta-catenin were altered in late compared to early passage cells. These pathways and affected genes may play a significant role in driving the cellular senescent phenotype and warrant further investigation as potential biomarkers of aging and senescence. These genes may additionally provide targets for intervention.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17286612 PMCID: PMC2049045 DOI: 10.1111/j.1474-9726.2007.00269.x
Source DB: PubMed Journal: Aging Cell ISSN: 1474-9718 Impact factor: 9.304
Experimental samples used for microarray analysis
| Donor | Clone | Time in culture (day) | Population doublings |
|---|---|---|---|
| OCTO 433 | 6 | 56 | 29.5 |
| OCTO 433 | 6 | 84 | 42.25 |
| OCTO 433 | 6 | 106 | 50 |
| OCTO 433 | 7 | 43 | 26 |
| OCTO 433 | 7 | 85 | 43.25 |
| OCTO 433 | 7 | 115 | 51 |
| OCTO 433 | 14 | 71 | 38.5 |
| OCTO 433 | 14 | 85 | 46.25 |
| OCTO 433 | 14 | 99 | 50.75 |
| OCTO 433 | 14 | 129 | 55.75 |
| OCTO 433 | 21 | 78 | 41.25 |
| OCTO 433 | 21 | 85 | 44.25 |
| OCTO 433 | 21 | 99 | 49.25 |
| OCTO 433 | 21 | 122 | 54.5 |
| OCTO 433 | 26 | 56 | 32.75 |
| OCTO 433 | 26 | 84 | 46.25 |
| OCTO 433 | 26 | 98 | 52.75 |
| OCTO 433 | 26 | 143 | 66.25 |
Genes differentially expressed larger than threefold up or down in T-cell clone (TCC) senescence as assessed by microarray analysis
| Gene name | Trend in senescence |
|---|---|
| Small inducible cytokine subfamily B (Cys-X-Cys), member 10 | Increased |
| Granulysin (GNLY), transcript variant 519 | Increased |
| CCL17 chemokine (C-C motif) ligand 17 | Increased |
| β-thromboglobulin-like protein (IL-8) | Increased |
| Interferon, α-inducible protein (clone IFI-6-16) | Increased |
| Adenosine A2a receptor | Increased |
| PTGS2 prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | Increased |
| Gap junction protein | Increased |
| CD5 antigen-like (scavenger receptor cysteine-rich family) | Increased |
| CD7 antigen (p41) | Increased |
| Interferon-induced cellular resistance mediator protein (MxB) | Increased |
| Neutrophil cytosolic factor 1 (47 kDa, chronic granulomatous disease, autosomal 1) | Increased |
| Early growth response 2 | Increased |
| Small inducible cytokine A2 | Increased |
| Small inducible cytokine A3 | Increased |
| Ferredoxin reductase | Increased |
| Relaxin 2 (H2) | Increased |
| Mitogen-induced nuclear orphan receptor (MINOR) | Increased |
| Zinc finger protein, subfamily 1A, 3 | Increased |
| Diphtheria toxin receptor (heparin-binding epidermal growth factor-like growth factor) | Increased |
| Lymphotoxin α (TNF superfamily, member 1) | Increased |
| Lymphotoxin β (TNF superfamily, member 3) | Increased |
| FLJ22635 fis | Increased |
| Tumor necrosis factor receptor superfamily, member 5 | Increased |
| Chemokine (C-C motif) receptor 7 (CCR7) | Increased |
| 2′,5′-oligoadenylate synthetase 1 | Increased |
| Aldolase C | Decreased |
| Human pregnancy-specific glycoprotein β-1 (SP1) | Decreased |
| Small inducible cytokine A4 | Decreased |
| Phosphoglycerate kinase 1 | Decreased |
| Early growth response 2 | Decreased |
| Δ-6 fatty acid desaturase | Decreased |
| NADH dehydrogenase (ubiquinone) 1 β subcomplex | Decreased |
| Nuclear receptor subfamily 4, group A, member 2 | Decreased |
| Vacuolar protein sorting 45B | Decreased |
| Insulin upstream factor 1 | Decreased |
| Δ-5 fatty acid desaturase | Decreased |
| Syntrophin 5; γ2-syntrophin | Decreased |
| Selectin L (lymphocyte adhesion molecule 1) | Decreased |
Experimental samples used for semiquantitative real-time reverse transcription-polymerase chain reaction (RT-PCR) analysis
| Donor | Clone | Time in culture (day) | Population doublings |
|---|---|---|---|
| OCTO 433 | 9 | 43 | 27 |
| OCTO 433 | 9 | 64 | 32.75 |
| OCTO 433 | 9 | 71 | 41 |
| OCTO 433 | 9 | 85 | 48.75 |
| OCTO 433 | 9 | 115 | 54.75 |
| OCTO 433 | 14 | 43 | 25.5 |
| OCTO 433 | 14 | 71 | 38.5 |
| OCTO 433 | 14 | 78 | 41.75 |
| OCTO 433 | 14 | 99 | 50.75 |
| OCTO 433 | 25 | 36 | 23.75 |
| OCTO 433 | 25 | 57 | 31.75 |
| OCTO 433 | 25 | 85 | 42.5 |
| OCTO 433 | 25 | 136 | 55.5 |
| OCTO 433 | 26 | 43 | 26.75 |
| OCTO 433 | 26 | 56 | 32.75 |
| OCTO 433 | 26 | 98 | 52.75 |
| OCTO 433 | 26 | 129 | 61.25 |
| OCTO 433 | 26 | 143 | 66.25 |
| OCTO 432 | 4 | 31 | 23 |
| OCTO 432 | 4 | 45 | 29.75 |
| OCTO 432 | 4 | 52 | 33.5 |
| OCTO 432 | 4 | 80 | 39.75 |
| OCTO 432 | 4 | 94 | 43.5 |
| OCTO 434 | 3 | 30 | 22.25 |
| OCTO 434 | 3 | 50 | 28.25 |
| OCTO 434 | 3 | 64 | 33.75 |
| OCTO 434 | 3 | 94 | 42.5 |
TaqMan (Applied Biosystems) probes used for real-time reverse transcription-polymerase chain reaction (RT-PCR)
| Gene | Probe reference |
|---|---|
| GJB1 | Hs00702141 |
| GNLY | Hs00246266 |
| IL-8 | Hs00174103 |
| MINOR (NR4A3) | Hs00175077 |
| CCL2 | Hs00234140 |
| CCL3 | Hs00234142 |
| ALDOC | Hs00193059 |
| ADORA2A | Hs00169123 |
| HBEGF | Hs00181813 |
| LTB | Hs00242737 |
| RLN2 | Hs00366471 |
| PTPN13 | Hs00196632 |
| CD7 | Hs00196191 |
| EGR2 | Hs00166165 |
| CXCL10 | Hs00171042 |
| TNFRSF5 | Hs01002912 |
| SELL | Hs00174151 |
| CD5L | Hs00234667 |
| CCL17 | Hs00171074 |
| CCR7 | Hs00171054 |
| GAPDH | Hs99999905 |
Main cellular functions of genes assessed by real-time reverse transcription-polymerase chain reaction (RT-PCR)
| Gene | Full name | Function |
|---|---|---|
| GJB1 | Gap junction protein | Member of the connexion family that assembles to form gap junction channels that facilitate transfer of ions between cells |
| GNLY | Granulysin | Protein present in cytotoxic granules of cytotoxic T lymphocytes and NK cells |
| IL-8 | Interleukin 8 | Cytokine involved in chemoattraction, angiogenesis, and activation of neutrophils |
| NR4A3 | Mitogen-induced nuclear orphan receptor | Member of the steroid-thyroid hormone-retinoid receptor superfamily |
| CCL2 | Small inducible cytokine A2 | Cytokine involved in immunoregulatory and inflammatory processes |
| CCL3 | Small inducible cytokine A3 | Macrophage inflammatory protein-1 involved in the acute inflammatory state in recruitment and activation of polymorphonuclear leukocytes |
| ALDOC | Aldolase C | Glycolytic enzyme that catalyzes the cleavage of fructose-1,6-biphosphate and fructose-1-phosphate |
| ADORA2A | Adenosine A2A receptor | G-protein coupled receptor family member which activates adenylyl cyclase |
| HBEGF | Heparin-binding epidermal growth factor-like growth factor | Plays a role in proliferation and differentiation |
| LTB | Lymphotoxin β receptor | Plays a role in the development and organization of lymphoid tissue |
| RLN2 | Relaxin 2 (H2) | Endocrine and autocrine/paracrine hormone that belongs to insulin gene superfamily |
| CD7 | CD7 antigen | Member of the immunoglobulin superfamily involved in T-cell interactions and lymphoid development |
| EGR2 | Early growth response 2 | Transcription factor. Mutations associated with Charcot-Marie-Tooth disease Type 1 |
| CXCL10 | Small inducible cytokine (Cys-X-Cys) member 10 | Interferon-γ-induced protein that binds CXCR3 causing stimulation of monocytes, NK and T-cell migration |
| TNFRSF5 | Tumor necrosis factor receptor superfamily, member 5 (CD40) | Essential in mediating a broad variety of immune and inflammatory responses including T-cell-dependent immunoglobulin class switching, memory B cell development, and germinal centre formation |
| SELL | Member of family of adhesion/homing receptors involved in leukocyte-endothelium interactions | |
| CD5L | CD5-antigen-like | |
| CCL17 | CCL17 chemokine (C-C motif) ligand 17 | Involved in T-cell development and trafficking and activation of mature T cells |
| CCR7 | Chemokine (C-C motif) receptor 7 | Involved in chemotaxis and migration dendritic cells |
| GAPDH | Glyceraldehyde-3-phosphate dehydrogenase | Housekeeper |
Genetic network altered in T-cell senescence
| Genes | Score | Focus genes | Top functions |
|---|---|---|---|
| 33 | 14 | Cellular movement; Haematological system development and function; Immune response |
Focus genes are shown in bold. Asterisks denote genes involved in multiple pathways.
Bold genes are those identified by microarray analysis.
Other genes listed were either not on the arrays or were not significantly regulated.
A score of > 3 was considered statistically significant (P < 0.001).
Fig. 1Network of genes differentially expressed in T-cell clone (TCC) immunosenescence. Forty-three genes that were differentially regulated in late passage, senescent, TCCs were analysed by the Ingenuity Pathway Analysis (IPA) tool. The network shown was significantly associated with cellular movement, haematological system development and function, immune response, cell-to-cell signaling and interaction, and cellular growth and proliferation (P < 0.01). Shaded genes were identified by microarray analysis as differentially expressed in TCC senescence. Other nodal genes are directly or indirectly associated with the differentially expressed genes. The meaning of the nodal shapes is indicated.